Valneva and Pfizer today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new…
Pauline Jung and Lukas Leiendecker from the Obenauf Lab won the very first edition of the President’s Prize of the Austrian Society of Dermatology and…
Valneva reported today its full year unaudited consolidated financial results for the year ending December 31, 2020 and summarized its key…
Valneva announced that it has initiated the clinical lot-to-lot consistency Phase 3 study for its single-shot chikungunya vaccine candidate, VLA1553.
The Max Perutz Labs are rebuilding key parts of the institute. The opening of the new entrance, reception, and study space for students marks a first…
Researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – unveil functional and mechanistic details in small…
The protein kinase Ataxia-telangiectasia mutated (ATM) is at the heart of the cellular response to DNA double-strand breaks (DSBs). Using…
Joao Matos was born in Portugal, did his PhD at the Max Planck Institute of Molecular Cell Biology and Genetics (Germany), and carried out…
Valneva reported that the UK Government has exercised its option to order 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate…
Valneva announced it has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies,…
The Plant Sciences Facility at Vienna Biocenter was interviewed in the Austrian national daily newspaper Die Presse about its high-tech research into…
Check full video on YouTube: https://www.youtube.com/watch?v=csci5pl_8gY
We thank our customers and supporters by showcasing some highlights as well…
The website uses cookies to ensure you get the best experience on our website.
Anonymous evaluation for troubleshooting and further development
Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics Storage period: data on your device for up to two years. Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.
